Heme Oxygenase-1 and Inflammation in Experimental Right Ventricular Failure on Prolonged Overcirculation-Induced Pulmonary Hypertension

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Belhaj, Asmae ^a,b,c   Dewachter, Laurence ^a   Kerbaul, François ^a,d   Brimioulle, Serge ^a,c   Dewachter, Céline ^a   Naeije, Robert ^a   Rondelet, Benoît ^a,b,c  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c ERASME HOSPITAL   (Belgium)

^d TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEME OXYGENASE 1; HEME OXYGENASE 2; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERLEUKIN 19; INTERLEUKIN 33; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENETIC CORRELATION; HEART RIGHT VENTRICLE FAILURE; ICAM 1 GENE; IL 19 GENE; IL 33 GENE; INFLAMMATION; LUNG VASCULAR RESISTANCE; NONHUMAN; PIGLET; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION; HEME OXYGENASE-1; HEMODYNAMICS; HYPERTENSION, PULMONARY; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKINS; SIGNAL TRANSDUCTION; SWINE; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84880818385     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069470     Document Type: Article

References (50)

1. Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, et al. (2009) Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 54: S55-66.
2. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, et al. (2010) Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 122: 156-163.
3. Champion HC, Michelakis ED, Hassoun PM, (2009) Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications. Circulation 120: 992-1007.
4. Haddad F, Hunt SA, Rosenthal DN, Murphy DJ, (2008) Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation 117: 1436-1448.
5. Rondelet B, Kerbaul F, Motte S, van Beneden R, Remmelink M, et al. (2003) Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension. Circulation 107: 1329-1335.
6. Rondelet B, Kerbaul F, Van Beneden R, Hubloue I, Huez S, et al. (2005) Prevention of pulmonary vascular remodeling and of decreased BMPR-2 expression by losartan therapy in shunt-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 289: H2319-2324.
7. Rondelet B, Kerbaul F, Van Beneden R, Motte S, Fesler P, et al. (2004) Signaling molecules in overcirculation-induced pulmonary hypertension in piglets: effects of sildenafil therapy. Circulation 110: 2220-2225.
8. Rondelet B, Dewachter C, Kerbaul F, Kang X, Fesler P, et al. (2012) Prolonged overcirculation-induced pulmonary arterial hypertension as a cause of right ventricular failure. Eur Heart J 33: 1017-1026.
9. Dewachter C, Dewachter L, Rondelet B, Fesler P, Brimioulle S, et al. (2010) Activation of apoptotic pathways in experimental acute afterload-induced right ventricular failure. Crit Care Med 38: 1405-1413.
10. Dewachter C, Dewachter L, Vercruyssen M, Rondelet B, Schraufnagel DP, et al. (2012) Inflammatory Processes In Load-Induced Right Ventricular Failure- Anti-Inflammatory Effects Of Epoprostenol. Am J Respir Crit Care Med 185: A3462.
11. Otterbein LE, Kolls JK, Mantell LL, Cook JL, Alam J, et al. (1999) Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest 103: 1047-1054.
12. Tenhunen R, Marver HS, Schmid R, (1968) The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A 61: 748-755.
13. Villamor E, Perez-Vizcaino F, Cogolludo AL, Conde-Oviedo J, Zaragoza-Arnaez F, et al. (2000) Relaxant effects of carbon monoxide compared with nitric oxide in pulmonary and systemic vessels of newborn piglets. Pediatr Res 48: 546-553.
14. Fredenburgh LE, Perrella MA, Mitsialis SA, (2007) The role of heme oxygenase-1 in pulmonary disease. Am J Respir Cell Mol Biol 36: 158-165.
15. Peyton KJ, Reyna SV, Chapman GB, Ensenat D, Liu XM, et al. (2002) Heme oxygenase-1-derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth. Blood 99: 4443-4448.
16. Brimioulle S, Maggiorini M, Stephanazzi J, Vermeulen F, Lejeune P, et al. (1999) Effects of low flow on pulmonary vascular flow-pressure curves and pulmonary vascular impedance. Cardiovasc Res 42: 183-192.
17. Brimioulle S, Wauthy P, Ewalenko P, Rondelet B, Vermeulen F, et al. (2003) Single-beat estimation of right ventricular end-systolic pressure-volume relationship. Am J Physiol Heart Circ Physiol 284: H1625-1630.
18. Winer J, Jung CK, Shackel I, Williams PM, (1999) Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270: 41-49.
19. Dewachter L, Adnot S, Fadel E, Humbert M, Maitre B, et al. (2006) Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension. Am J Respir Crit Care Med 174: 1025-1033.
20. Winer BJ, Brown DR, Michels KM (1991) Statistical Principles in Experimental Design. eds. Chiappetta ME, Vaicunas J, Morris JM. 3rd edition. New York: Mc-Graw-Hill, 220-283.
21. Wauthy P, Kafi AS, Mooi W, Naeije R, Brimioulle S, (2003) Effects of nitric oxide and prostacyclin in an over-circulation model of pulmonary hypertension. J Thorac Cardiovasc Surg 125: 1430-7.
22. Naeije R, Westerhof N (2011) Pulmonary vascular function. In Textbook of Pulmonary Vascular Diseases. Edited by XJ Yuan, GJN Garcia, CA Hales, S Rich, SL Archer, JB West. Springer, Chap 4, 61-72.
23. Hassoun PM, Mouthon L, Barbera JA, Eddahibi S, Flores SC, et al. (2009) Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol 54: S10-19.
24. Bogaard HJ, Abe K, Vonk Noordegraaf A, Voelkel NF, (2009) The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest 135: 794-804.
25. Sungprem K, Khongphatthanayothin A, Kiettisanpipop P, Chotivitayatarakorn P, Poovorawan Y, et al. (2009) Serum level of soluble intercellular adhesion molecule-1 correlates with pulmonary arterial pressure in children with congenital heart disease. Pediatr Cardiol 30: 472-476.
26. Li XQ, Wang HM, Yang CG, Zhang XH, Han DD, et al. (2011) Fluoxetine inhibited extracellular matrix of pulmonary artery and inflammation of lungs in monocrotaline-treated rats. Acta Pharmacol Sin 32: 217-222.
27. Burke DL, Frid MG, Kunrath CL, Karoor V, Anwar A, et al. (2009) Sustained hypoxia promotes the development of a pulmonary artery-specific chronic inflammatory microenvironment. Am J Physiol Lung Cell Mol Physiol 297: L238-250.
28. Satoh K, Fukumoto Y, Nakano M, Sugimura K, Nawata J, et al. (2009) Statin ameliorates hypoxia-induced pulmonary hypertension associated with down-regulated stromal cell-derived factor-1. Cardiovasc Res 81: 226-234.
29. Li M, Scott DE, Shandas R, Stenmark KR, Tan W, (2009) High pulsatility flow induces adhesion molecule and cytokine mRNA expression in distal pulmonary artery endothelial cells. Ann Biomed Eng 37: 1082-1092.
30. Miller AM, (2011) Role of IL-33 in inflammation and disease. J Inflamm 8: 22.
31. Demyanets S, Konya V, Kastl SP, Kaun C, Rauscher S, et al. (2010) Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 31: 2080-2089.
32. Kakkar R, Hei H, Dobner S, Lee RT, (2012) Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J Biol Chem 287: 6941-6948.
33. Daley E, Emson C, Guignabert C, de Waal Malefyt R, et al. (2008) Pulmonary arterial remodeling induced by a Th2 immune response. J Exp Med 205: 361-372.
34. Tian Y, Sommerville LJ, Cuneo A, Kelemen SE, Autieri MV, (2008) Expression and suppressive effects of interleukin-19 on vascular smooth muscle cell pathophysiology and development of intimal hyperplasia. Am J Pathol 173: 901-909.
35. Masri FA, Xu W, Comhair SA, Asosingh K, Koo M, et al. (2007) Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 293: L548-554.
36. Mathew R, Huang J, Shah M, Patel K, Gewitz M, et al. (2004) Disruption of endothelial-cell caveolin-1alpha/raft scaffolding during development of monocrotaline-induced pulmonary hypertension. Circulation 110: 1499-1506.
37. Gabunia K, Ellison SP, Singh H, Datta P, Kelemen SE, et al. (2012) Interleukin-19 (IL-19) induces heme oxygenase-1 (HO-1) expression and decreases reactive oxygen species in human vascular smooth muscle cells. J Biol Chem 287: 2477-2484.
38. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, et al. (2004) Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22: 929-979.
39. Abraham NG, Kushida T, McClung J, Weiss M, Quan S, et al. (2003) Heme oxygenase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circ Res 93: 507-514.
40. Vergadi E, Chang MS, Lee C, Liang OD, Liu X, et al. (2011) Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension. Circulation 123: 1986-1995.
41. Christou H, Morita T, Hsieh CM, Koike H, Arkonac B, et al. (2000) Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Circ Res 86: 1224-1229.
42. Minamino T, Christou H, Hsieh CM, Liu Y, Dhawan V, et al. (2001) Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci U S A 98: 8798-8803.
43. Zhou H, Liu H, Porvasnik SL, Terada N, Agarwal A, et al. (2006) Heme oxygenase-1 mediates the protective effects of rapamycin in monocrotaline-induced pulmonary hypertension. Lab Invest 86: 62-71.
44. Dorfmuller P, Chaumais MC, Giannakouli M, Durand-Gasselin I, Raymond N, et al. (2001) Increased oxidative stress and severe arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension. Respir Res 12: 119.
45. Vitali SH, Mitsialis SA, Liang OD, Liu X, Fernandez-Gonzalez A, et al. (2009) Divergent cardiopulmonary actions of heme oxygenase enzymatic products in chronic hypoxia. PLoS One 4: e5978.
46. Liang OD, Mitsialis SA, Chang MS, Vergadi E, Lee C, et al. (2011) Mesenchymal stromal cells expressing heme oxygenase-1 reverse pulmonary hypertension. Stem Cells 29: 99-107.
47. Katayose D, Isoyama S, Fujita H, Shibahara S, (1993) Separate regulation of heme oxygenase and heat shock protein 70 mRNA expression in the rat heart by hemodynamic stress. Biochem Biophys Res Commun 191: 587-594.
48. Bogaard HJ, Natarajan R, Henderson SC, Long CS, Kraskauskas D, et al. (2009) Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. Circulation 120: 1951-1960.
49. Takeuchi M, Takahashi T, Taga N, Iwasaki T, Ohe K, et al. (2003) Right ventricle of patients undergoing congenital cardiac surgery differentially expresses haem oxygenase-1 and heat shock protein 70 genes. J Int Med Res 31: 413-417.
50. Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, et al. (2007) IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 117: 1538-1549.